{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T07:00:25Z","timestamp":1773903625746,"version":"3.50.1"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2005,10,7]],"date-time":"2005-10-07T00:00:00Z","timestamp":1128643200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2006,5]]},"DOI":"10.1007\/s10067-005-0024-1","type":"journal-article","created":{"date-parts":[[2005,10,6]],"date-time":"2005-10-06T11:44:57Z","timestamp":1128599097000},"page":"384-388","source":"Crossref","is-referenced-by-count":51,"title":["Rheumatoid lung nodulosis and osteopathy associated with leflunomide therapy"],"prefix":"10.1007","volume":"25","author":[{"given":"Alexander","family":"Rozin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mordechai","family":"Yigla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luda","family":"Guralnik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zohar","family":"Keidar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Euvgeni","family":"Vlodavsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Rozenbaum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abraham Menahem","family":"Nahir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra","family":"Balbir-Gurman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2005,10,7]]},"reference":[{"key":"24_CR1","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1002\/art.11015","volume":"48","author":"JR Kalden","year":"2003","unstructured":"Kalden JR, Schattenkirchner M, Sorensen H et al (2003) The efficacy and safety of leflunomide in patients with active rheumatoid arthritis: a five-year follow-up study. Arthritis Rheum 48:1513\u20131520","journal-title":"Arthritis Rheum"},{"key":"24_CR2","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/S0140-6736(04)15969-2","volume":"363","author":"DL Scott","year":"2004","unstructured":"Scott DL (2004) Interstitial lung disease and disease modifying anti-rheumatic drugs. Lancet 363:1239\u20131240","journal-title":"Lancet"},{"key":"24_CR3","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0140-6736(04)15527-X","volume":"363","author":"J McCurry","year":"2004","unstructured":"McCurry J (2004) Japan deaths spark concerns over arthritis drug. Lancet 363:461","journal-title":"Lancet"},{"key":"24_CR4","first-page":"S561","volume":"50","author":"GW Cannon","year":"2004","unstructured":"Cannon GW, Strand V, Simon LS, Kavanaugh AF, Hochberg MC, Scarazzini L, Holden WL (2004) Interstitial lung disease in rheumatoid arthritis patients receiving leflunomide. Arthritis Rheum 50:S561","journal-title":"Arthritis Rheum"},{"key":"24_CR5","first-page":"S561","volume":"50","author":"GW Cannon","year":"2004","unstructured":"Cannon GW, Strand V, Scarazzini L, Holden WL (2004) Comparison of adverse event reporting rates for etanercept, infliximab, leflunomide and methotrexate between September 1998 and June 2003. Arthritis Rheum 50:S561","journal-title":"Arthritis Rheum"},{"key":"24_CR6","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/s00393-004-0537-z","volume":"63","author":"MG Braun","year":"2004","unstructured":"Braun MG, Van Rhee R, Becker-Capeller D (2004) Development and\/or increase of rheumatoid nodules in RA patients following leflunomide therapy. Z Rheumatol 63:84\u201387","journal-title":"Z Rheumatol"},{"key":"24_CR7","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1136\/ard.2003.018440","volume":"63","author":"J Grisar","year":"2004","unstructured":"Grisar J, Aringer M, Koller MD, Stummvoll GH, Eselbock D, Zwolfer B et al (2004) Leflunomide inhibits transendothelial migration of peripheral blood mononuclear cells. Ann Rheum Dis 63:1632\u20131637","journal-title":"Ann Rheum Dis"},{"key":"24_CR8","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/art.1780340126","volume":"34","author":"P Langevitz","year":"1991","unstructured":"Langevitz P, Maguire L, Urowitz M (1991) Accelerated nodulosis during azathioprine therapy. Arthritis Rheum 34:123\u2013124","journal-title":"Arthritis Rheum"},{"key":"24_CR9","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1002\/art.10096","volume":"46","author":"J Kekow","year":"2002","unstructured":"Kekow J, Welte T, Kellner U, Pap T (2002) Development of theumatoid nodules during anti-tumor necrosis factor alpha therapy with etanercept. Arthritis Rheum 46:843\u2013844","journal-title":"Arthritis Rheum"},{"key":"24_CR10","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/art.10535","volume":"47","author":"G Cunnane","year":"2002","unstructured":"Cunnane G, Warnock M, Fye KH, Daikh DI (2002) Accelerated nodulosis and vasculitis following etanercept therapy for rheumatoid arthritis. Arthritis Rheum 47:445\u2013449","journal-title":"Arthritis Rheum"},{"key":"24_CR11","first-page":"75","volume":"14","author":"A Spadaro","year":"1994","unstructured":"Spadaro A, Fiore D, Iagnocco A, Riccieri V, Sili Scavalli A, Coari G, Taccari E, Zoppini A (1994) Rheumatoid nodules and cyclosporin A treatment. Int J Clin Pharmacol Res 14:75\u201378","journal-title":"Int J Clin Pharmacol Res"},{"key":"24_CR12","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1002\/1529-0131(199707)40:7<1308::AID-ART16>3.0.CO;2-M","volume":"40","author":"JT Merrill","year":"1997","unstructured":"Merrill JT, Shen C, Schreibman D, Coffey D, Zakharenko O, Fisher R, Lahita RG, Salmon J, Cronstein BN (1997) Adenosin A1 receptor promotion of multinucleated giant cell formation by human monocytes: a mechanism for methotrexate-induced nodulosis in rheumatoid arthritis. Arthritis Rheum 40:1308\u20131315","journal-title":"Arthritis Rheum"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-005-0024-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-005-0024-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-005-0024-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T08:42:43Z","timestamp":1559119363000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-005-0024-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10,7]]},"references-count":12,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,5]]}},"alternative-id":["24"],"URL":"https:\/\/doi.org\/10.1007\/s10067-005-0024-1","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,10,7]]}}}